As part of the 2025 World Cancer Leaders’ Summit, Monash Partners Comprehensive Cancer Consortium (MPCCC) welcomed international delegates from across Asia, Africa, the Middle East and Europe for an afternoon of learning, exchange and connection.

During the visit, each guest was invited to place a response card on a world map answering two simple prompts: One thing I learnt from MPCCC is… and One thing MPCCC could implement is… The result was a powerful and visual snapshot of how MPCCC’s work is being perceived on the global stage.

What the world learnt from MPCCC

Across countries and disciplines, a common message emerged: MPCCC is seen as a practical, scalable model for equity-driven cancer care.

Delegates repeatedly highlighted the value of MPCCC’s decentralised, networked approach. A radiation oncologist and research lead from the Philippines noted the importance of “linking research, clinic, education and policymaking to enable early uptake of innovation and equitable access.”

From Japan, a UICC representative recognised the strength of MPCCC’s innovation potential, suggesting it as a model for connecting communities to clinical trials through digital tools. 

A patient advocate from Morocco described learning about the “postcode effect” in access to care, and how MPCCC’s commitment to decentralisation and locally-grounded action offers a pathway to more equitable, personalised cancer care worldwide.

Several delegates shared similar reflections:

• “Comprehensive, ‘leave no one behind’ thinking”
  
  
• “A trusted and supported network”
  
  
• “Right drug, right patient, right time”
  
  
• “Strong coordination and clarity of purpose”
  
  
• “Multidisciplinary, collaborative and equity-centred”
  
  

For some, the experience was eye-opening. A Nigerian operations manager shared, “We don’t have anything like MPCCC in Nigeria. How coordinated your system is was very inspiring – hopefully one day we could adopt a model like this at home.”

‍

Ideas for the future 

Just as importantly, delegates were also generous in sharing what MPCCC could strengthen or expand, offering ideas that reflect the consortium’s openness to listening, learning and evolving.

Recurring suggestions included:

• Developing toolkits and best-practice guidelines that can be shared internationally
  
  
• Publishing the MPCCC model from concept to community, including governance and auditing methods
  
  
• Strengthening digital and app-based platforms to connect patients to trials and services
  
  
• Supporting capacity building in low-resource settings
  
  
• Expanding collaboration into regions such as Africa, South East Asia and China
  
  
• Increasing visible work in supportive and psychosocial care
  
  
• Sharing success stories more widely on a global stage
  
  

As one delegate from Hong Kong reflected, “Patients are ambassadors. Their stories highlight not only the medical, but the psychosocial aspects of the cancer journey.”

A global footprint on a local map

When the final card was placed, the world map displayed a visual representation of MPCCC’s growing global influence. Proof that a locally-based consortium can inform, inspire and support cancer systems internationally.

These reflections will directly inform MPCCC’s next phase of strategic planning, partnership development and international engagement.

Because in the words of one delegate from Nigeria:
“We don’t have to wait to have it all together in one centre of excellence. Quality of care can – and must – extend beyond the city.”

And that is exactly what MPCCC is working to make possible.

‍